• Propecia Does Not Increase Prostate Cancer Risk According to Chief Medical Officer of The American Cancer Society

    The news has spread far and wide through the hair loss community that the Food and Drug Administration expanded their warning last Thursday on a group of drugs which includes finasteride (Proscar/Propecia), stating that using these drugs may increase the risk of high grade prostate cancer.

    The latest  warning indicates that 5 alpha reductase inhibitors (which include the hair loss drug Propecia) are linked to a greater risk of high grade prostate cancers. However, many physicians, including prostate cancer specialists, believe that these drugs actually improve the ability to detect aggressive tumors that already exist in patients, which can prove to be life saving.

    According to Otis Brawley, M.D., chief medical officer and executive vice president of the American Cancer Society, this latest FDA warning has been misinterpreted by many and he felt it was important to set the record straight.

    Spencer Kobren speaks with Dr. Otis Brawley of The American Cancer Society

     
  • Genes May Predict Treatment Efficacy For Women Suffering With Hair Loss

    A six month pilot study conducted by molecular dermatology and research innovator Hair DX, suggests that certain genetic mechanisms can help predict if the breakthrough hair loss drug Propecia (Finasteride), primary prescribed to men, could actually be effective in the treatment of female pattern hair loss in post menopausal women.

    “Results of our pilot study are very encouraging, as it appears we have found a key piece of the genetic puzzle which identifies women who can benefit from Finasteride therapy in the same way men do. Our findings suggest these women actually have a female corollary to male pattern hair loss (Androgenetic Alopecia), and that is an important finding,” says IAHRS Accepted Member Dr. Sharon Keene, Chief Medical Officer of HairDX. “Once these results are confirmed, it can usher in a new era of treatment for female Androgenetic Alopecia.”

    Read Full Story:

    http://www.news-medical.net/news/20100224/Study-indicates-Finasteride-therapy-may-benefit-women-suffering-from-hair-loss.aspx

     
  • Setting Hair Restoration Goals

    Setting goals may be the most challenging aspect of planning hair restoration.  Many of us can be emotionally devastated by our hair loss.  We tend to want to fix what’s missing right now.

    Until hair cloning, hair multiplication, gene therapy, or anything else becomes viable and affordable, we are left to work within the confines of our available donor supplies.  And for the sake of our discussion, our references will be to scalp donor.   Hair harvested from other regions of the body are methodology still in their infancy stages and because of the lack of consistent results (yields), we cannot and will not rely on it as a realistic or feasible donor source.  Hopefully that will change in the near future.

    Hair restoration is an all encompassing term and extends beyond the realm of surgery.  First and foremost, patients have to decide if they will use the available medications approved by the FDA for treating MPB. Interestingly enough, the earlier an individual decides to begin treatment after formal diagnosis, the better overall results achieved including regrowth.  These medications are Propecia (men only, finasteride 1mg daily), and Rogaine (minoxidil 3% & 5% strength).   Why is this an important element in setting one’s goals? We know that MPB is a progressive disorder in its nature so without the effective use of hair loss medications, the loss will continue in its predestined course.  Read more ›

     
 
 

Subscribe

Enter your email address:

 
 

"Spencer Kobren's nationally syndicated show "The Bald Truth" has a dedicated listenership that would have Rush Limbaugh pulling his hair out in envy." --Pittsburgh Tribune-Review.

 
 
 
 
 

BaldTruthTalk Forums

 
 

Talk

 
 
 
 
 
 

News